Computer-aided Drug Discovery Approaches in the Identification of Natural Products against SARS-CoV-2: A Review
MM Junqueira Ribeiro - Current Computer-Aided Drug Design, 2024 - ingentaconnect.com
The COVID-19 pandemic is raising a worldwide search for compounds that could act against
the disease, mainly due to its mortality. With this objective, many researchers invested in the …
the disease, mainly due to its mortality. With this objective, many researchers invested in the …
Computational Approaches to Discover Novel Phytochemical Inhibitors Against Novel Coronavirus (Sars-CoV-2)
R SATPATHY - Computational Biology in Drug Discovery and …, 2024 - books.google.com
Plants are considered large sources of molecules so it remains in a central position in the
drug discovery process to find the appropriate lead molecules. The major aspect is to …
drug discovery process to find the appropriate lead molecules. The major aspect is to …
Natural substances in the fight of SARS-CoV-2: A critical evaluation resulting from the cross-fertilization of molecular modeling data with the pharmacological aspects
The recent pandemic due to SARS-CoV-2, the last isolated human betacoronavirus, has
revolutionized modern knowledge of the pathogenesis of viral pneumonia. The lack of …
revolutionized modern knowledge of the pathogenesis of viral pneumonia. The lack of …
In silico investigation and potential therapeutic approaches of natural products for COVID-19: Computer-aided drug design perspective
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a
substantial number of deaths around the world, making it a serious and pressing public …
substantial number of deaths around the world, making it a serious and pressing public …
An Integrated In Silico and In Vitro Approach for the Identification of Natural Products Active against SARS-CoV-2
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has provoked a global health crisis due to the absence of a …
coronavirus 2 (SARS-CoV-2), has provoked a global health crisis due to the absence of a …
Anti–SARS-CoV-2 natural products as potentially therapeutic agents
CH Kim - Frontiers in pharmacology, 2021 - frontiersin.org
Severe acute respiratory syndrome–related coronavirus-2 (SARS-CoV-2), a β-coronavirus,
is the cause of the recently emerged pandemic and worldwide outbreak of respiratory …
is the cause of the recently emerged pandemic and worldwide outbreak of respiratory …
An Overview of Coronaviruses: In-Silico Approach to Decipher Anti-SARS-CoV-2 Natural Products
In current study, we have focused on the outline of different coronaviruses including COVID-
19, along with potential therapeutic targets of SARC-CoV-2. Moreover, experimentally …
19, along with potential therapeutic targets of SARC-CoV-2. Moreover, experimentally …
Efficient identification of anti-SARS-CoV-2 compounds using chemical structure-and biological activity-based modeling
Identification of anti-SARS-CoV-2 compounds through traditional high-throughput screening
(HTS) assays is limited by high costs and low hit rates. To address these challenges, we …
(HTS) assays is limited by high costs and low hit rates. To address these challenges, we …
In Silico Drug Discovery: The Next Frontier in the Fight Against SARS-CoV-2
CR Wei, GC Lang'at - 2023 - preprints.org
Covid-19 is one of humanity's biggest threat in the 21st century with WHO figures reporting
636 million cases and up to 6.6 million deaths globally. SARS-CoV-2, the virus that causes …
636 million cases and up to 6.6 million deaths globally. SARS-CoV-2, the virus that causes …
Insights into In Silico Methods to Explore Plant Bioactive Substances in Combating SARS-CoV-2
SARS-CoV-2 is a virus belonging to the species “severe acute respiratory syndrome-related
coronavirus”(SARSr-CoV), a strain that causes the respiratory sickness driving the …
coronavirus”(SARSr-CoV), a strain that causes the respiratory sickness driving the …